Skip to content
10-Q

Quarterly Report

Sio Gene Therapies Inc.

0001636050-22-000050

← back to feed
Filed
Nov 10, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Nov 8, 2022 73.98M sh
Shares Diluted Q2 2023 · Sep 30, 2022 73.98M sh
Shares Diluted Q2 2023 · Sep 30, 2022 73.87M sh
Shares Diluted Q2 2023 · Sep 30, 2021 72.94M sh
Shares Diluted Q2 2023 · Sep 30, 2021 72.9M sh
Operating Cash Flow Q2 2023 · Sep 30, 2022 −$13.76M
Operating Cash Flow Q2 2023 · Sep 30, 2021 −$21.92M
Cash And Equivalents Q2 2023 · Sep 30, 2022 $49.87M
Cash And Equivalents Q2 2023 · Mar 31, 2022 $63.73M
Cash And Equivalents Q2 2023 · Sep 30, 2021 $101.7M
Cash And Equivalents Q2 2023 · Mar 31, 2021 $118.99M
Stockholders Equity Q2 2023 · Sep 30, 2022 $48.91M
Stockholders Equity Q2 2023 · Jun 30, 2022 $51.78M
Stockholders Equity Q2 2023 · Mar 31, 2022 $60.35M
Stockholders Equity Q2 2023 · Sep 30, 2021 $99.36M
Stockholders Equity Q2 2023 · Jun 30, 2021 $113.3M
Stockholders Equity Q2 2023 · Mar 31, 2021 $123.37M
Current Liabilities Q2 2023 · Sep 30, 2022 $4.83M
Current Liabilities Q2 2023 · Mar 31, 2022 $13M
Total Liabilities Q2 2023 · Sep 30, 2022 $4.83M
Total Liabilities Q2 2023 · Mar 31, 2022 $14.73M
Current Assets Q2 2023 · Sep 30, 2022 $53.74M
Current Assets Q2 2023 · Mar 31, 2022 $71.74M
Total Assets Q2 2023 · Sep 30, 2022 $53.75M
Total Assets Q2 2023 · Mar 31, 2022 $75.08M
Eps Diluted Q2 2023 · Sep 30, 2022 −$0.04
Eps Diluted Q2 2023 · Sep 30, 2022 −$0.16
Eps Diluted Q2 2023 · Sep 30, 2021 −$0.29
Eps Diluted Q2 2023 · Sep 30, 2021 −$0.45
Eps Basic Q2 2023 · Sep 30, 2022 −$0.04
Eps Basic Q2 2023 · Sep 30, 2022 −$0.16
Eps Basic Q2 2023 · Sep 30, 2021 −$0.29
Eps Basic Q2 2023 · Sep 30, 2021 −$0.45
Sga Expense Q2 2023 · Sep 30, 2022 $2.94M
Sga Expense Q2 2023 · Sep 30, 2022 $5.93M
Sga Expense Q2 2023 · Sep 30, 2021 $9.75M
Sga Expense Q2 2023 · Sep 30, 2021 $13.61M
Rd Expense Q2 2023 · Sep 30, 2022 $336K
Rd Expense Q2 2023 · Sep 30, 2022 $5.88M
Rd Expense Q2 2023 · Sep 30, 2021 $11.45M
Rd Expense Q2 2023 · Sep 30, 2021 $19.51M
Net Income Q2 2023 · Sep 30, 2022 −$3.08M
Net Income Q2 2023 · Sep 30, 2022 −$11.49M
Net Income Q2 2023 · Jun 30, 2022 −$8.41M
Net Income Q2 2023 · Mar 31, 2022 −$71.9M
Net Income Q2 2023 · Sep 30, 2021 −$21.24M
Net Income Q2 2023 · Sep 30, 2021 −$33.11M
Net Income Q2 2023 · Jun 30, 2021 −$11.87M
Operating Income Q2 2023 · Sep 30, 2022 −$3.08M
Operating Income Q2 2023 · Sep 30, 2022 −$11.49M
Operating Income Q2 2023 · Sep 30, 2021 −$21.24M
Operating Income Q2 2023 · Sep 30, 2021 −$33.14M